Navigation Links
SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the World's First Prototype for its Next Generation Application for Drug Safety Administration
Date:12/5/2012

JERUSALEM, December 5, 2012 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC)(the "Company"), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, is pleased to announced it has identified and is commencing to develop the world's first prototype for its next generation application for Drug Safety Administration. The prototype development and the technology application is expected to be completed within 4-6 months and will be then demonstrated to worldwide major drug container manufacturers for possible adoption to ensure a new generation drug administration safety application.

The Company recently launched its new website which has also been optimized for accessibility and easy navigation on smartphones and tablets as well as laptops and home computers.  

In conjunction with the website unveiling, the Company has published a new video demonstrating the SafeCode voice-activation technology as a novel product candidate for the medical industry.  Investors are encouraged to view the video on the Company's website or on YouTube at http://www.youtube.com/watch?v=PEy9ygT6jaA.

Across the past month, the Company has been granted eligibility status by the Depository Trust Company and commenced trading on the OTC Bulletin Boards.

"We are dedicated to providing a high-quality product and transparency to our stakeholders. We are taking all necessary steps to meet these corporate goals and doing so in an expeditious manner," said Joel Klopfer, Chief Executive Officer at SafeCode Drug Technologies Corp.  "Accidental deaths resulting from administering incorrect medication represent a multi-billion-dollar area of unmet need.  We believe that we have a solution with our patent-pending voice-recognition technology that will benefit manufacturers, pharmacists and patients while building our corporate value.  This is an exciting time for our company and shareholders as we enter the commercialization phase.  The new website was important to us as it showcases the SafeCode solution while giving investors fast, user-friendly access to information on our company."

About SafeCode Drug Technologies

SafeCode Drug Technologies Corporation is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.  

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov

Contact:
Joel Klopfer
Joel.Klofer1@gmail.com
+9722-5021322

 



'/>"/>
SOURCE Safecode Drug Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
2. SafeCode Drug Technologies Corp. in Negotiations With Manufacturers to Develop Prototype
3. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
4. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
5. Innovative CA Tumor Marker Tests Technologies and Emerging Markets
6. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
7. UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
8. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
9. DenMat Announces Signing a Purchase Agreement to Acquire PeriOptix Inc., Leading Provider of Magnification and Illumination Technologies
10. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
11. CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... N.J. , June 23, 2016  Guerbet announced ... Premier Inc.,s Supplier Horizon Award . ... year, Guerbet was recognized for its support of Premier ... creation through clinical excellence, and commitment to lower costs. ... to receive this recognition of our outstanding customer service ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone ... executive with extensive sequencing and genomics experience, as Vice President of North American Capital ... will be responsible for leading the sales team in the commercialization of the HTG ...
Breaking Medicine News(10 mins):